Mitochondria-targeted esculetin
Intervention1 paper4 findings
- Animals1
Outcomes
4p38 MAPK signalling
downin mouse cells1Very low certainty
1 study
p38 MAPK signalling
downin mouse cells1Very low certainty
Mitochondria-targeted esculetin inhibits p38 MAPK signalling in mouse cells.
Cellsin H9c2 cardiomyocytes and primary adult mouse cardiac fibroblasts
Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026
AMPK signalling
upin mouse cells1Very low certainty
1 study
AMPK signalling
upin mouse cells1Very low certainty
Mitochondria-targeted esculetin activates AMPK signalling in mouse cells.
Cellsin H9c2 cardiomyocytes and primary adult mouse cardiac fibroblasts
Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026
Fibrosis
downin mice1Very low certainty
1 study
Fibrosis
downin mice1Very low certainty
Mitochondria-targeted esculetin decreases fibrosis in mice.
Animalsaged Apoe-/- mice
Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026
Cardiac hypertrophy
downin mice1Very low certainty
1 study
Cardiac hypertrophy
downin mice1Very low certainty
Mitochondria-targeted esculetin decreases cardiac hypertrophy in mice.
Animalsaged Apoe-/- mice
Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026